Melanoma Cases Across 8MM to Reach 263,000 by 2035

Diagnosed incident cases of melanoma across eight major global markets are projected to reach 263,000 by 2035, climbing at an annual growth rate of 1.47% from an estimated 229,000 cases in 2025, according to a recent epidemiology report and forecast from GlobalData. The data highlights significant regional disparities in skin cancer incidence driven by geographic location, environmental factors, and demographic vulnerabilities.

US and International Melanoma Case Projections Through 2035

The United States will record the highest volume of diagnosed melanoma cases among the evaluated regions, crossing 130,000 cases by 2035, according to GlobalData’s findings. The research evaluates the 8MM, which comprises the US, France, Germany, Italy, Spain, the UK, Canada, and Australia.

Other regions face substantial diagnostic totals over the next decade. Canada is estimated to reach approximately 14,000 cases, while Australia will record around 21,000 diagnosed incident cases by 2035. Meanwhile, the 5EU nations—comprising France, Germany, Italy, Spain, and the UK—are projected to account for a combined total of roughly 88,000 cases.

Ultraviolet Exposure and Geographic Risk Factors in Australia

Ultraviolet radiation serves as a primary risk factor for melanoma development. According to GlobalData epidemiologists, Australia exhibits markedly higher incidence rates relative to other analyzed countries. This heightened disease burden stems from a convergence of environmental exposure and biological susceptibility.

“The discrepancy between incidence rates of melanoma in Australia and those in all other markets may be explained by a combination of its location on the southern hemisphere, its proximity to the equator, and a considerable number of its population with fair skin,” said Robyn Jones, Epidemiologist at GlobalData.

Countries situated in the Southern Hemisphere position closer to the sun during their respective summer months. Australia’s nearness to the equator further intensifies ultraviolet exposure due to specific atmospheric conditions and solar positioning. These geographic realities, when paired with a demographic makeup featuring a high proportion of fair-skinned residents, amplify individual susceptibility to radiation damage.

Public Health Successes and Stage 1 Diagnoses

Despite rising overall case numbers, clinical data shows a positive trend in how the disease is identified. GlobalData epidemiologists observed that stage 1 diagnoses represent the majority of recorded incident cases across every examined market, though exact proportions fluctuate.

“The high proportion of early diagnosis likely reflects considerable progress in public awareness of the risks of UV exposure and melanoma,” Jones stated. Public health protection initiatives designed to educate communities on recognizing early symptoms, alongside multi-pronged interventions, have effectively curbed ultraviolet exposure and promoted prompt clinical evaluations.

Frequently Asked Questions

What is the projected growth rate for melanoma cases?

According to GlobalData, diagnosed incident cases of melanoma across the 8MM are expected to grow at an annual rate of 1.47%, rising from 229,000 in 2025 to 263,000 cases in 2035.

Which country will have the highest number of melanoma cases by 2035?

The United States is projected to have the highest burden, with just over 130,000 diagnosed incident cases in 2035.

Why does Australia have higher melanoma incidence rates than other regions?

According to GlobalData epidemiologists, Australia’s high rates stem from its Southern Hemisphere location, proximity to the equator, and a large population with fair skin, which collectively increase both UV exposure and biological susceptibility.

At what stage are most melanoma cases diagnosed?

Data indicates that cases are most frequently diagnosed at stage 1, representing the majority of incident cases across all evaluated markets due to improved public awareness and early detection campaigns.